Herceptin and Tykerb effective against a subset of gastric cancers

A combination of two targeted therapies already shown to be effective in breast cancer packs an effective one-two punch against a subset of gastric cancers that have a specific genetic mutation, a study at UCLA's Jonsson Comprehensive Cancer Center has found.

Read the whole article on Physorg

More from Physorg